These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. Sawyers CL; Timson L; Kawasaki ES; Clark SS; Witte ON; Champlin R Proc Natl Acad Sci U S A; 1990 Jan; 87(2):563-7. PubMed ID: 2405384 [TBL] [Abstract][Full Text] [Related]
44. Bone marrow transplantation for leukaemia--current status and strategies for improvement. Appelbaum FR Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S4-6. PubMed ID: 15651181 [TBL] [Abstract][Full Text] [Related]
45. [Indications, technique and risks in bone marrow transplantation in adulthood]. Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901 [TBL] [Abstract][Full Text] [Related]
46. bcr/abl mRNA detection following bone marrow transplantation for chronic myelogenous leukemia. Ely P; Miller WJ Transplantation; 1991 Dec; 52(6):1023-8. PubMed ID: 1750065 [TBL] [Abstract][Full Text] [Related]
47. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease. Aschan J; Ringdén O Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365 [TBL] [Abstract][Full Text] [Related]
48. Pneumatosis intestinalis in children after allogeneic bone marrow transplantation. Yeager AM; Kanof ME; Kramer SS; Jones B; Saral R; Lake AM; Santos GW Pediatr Radiol; 1987; 17(1):18-22. PubMed ID: 3547276 [TBL] [Abstract][Full Text] [Related]
49. Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies. Ohnuma K; Isoyama K; Ikuta K; Toyoda Y; Nakamura J; Nakajima F; Tsuchida M; Ohira M; Suminoe A; Hara T; Nishihira H Br J Haematol; 2001 Mar; 112(4):981-7. PubMed ID: 11298596 [TBL] [Abstract][Full Text] [Related]
50. Use of the polymerase chain reaction to monitor engraftment following allogeneic bone marrow transplantation. Chalmers EA; Sproul AM; Mills KI; Gibson BE; Burnett AK Bone Marrow Transplant; 1990 Dec; 6(6):399-403. PubMed ID: 2097008 [TBL] [Abstract][Full Text] [Related]
51. Allogeneic bone marrow transplantation for leukaemia and aplastic anaemia. Results of the Leipzig BMT Group. Helbig W; Kubel M; Schwenke H; Thierbach V; Hoffmann FA; Standke E; Feyer P; Haustein B; Pönisch W Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):383-7. PubMed ID: 2480278 [TBL] [Abstract][Full Text] [Related]
52. [Molecular analysis of bcr/abl mRNA in chronic myelogenous leukemia after bone marrow transplantation by using RT-PCR method]. Nakamura K; Mizutani S; Matsue T Rinsho Ketsueki; 1992 Apr; 33(4):436-44. PubMed ID: 1602606 [TBL] [Abstract][Full Text] [Related]
53. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation. Santini V; Zoccolante A; Bosi A; Guidi S; Saccardi R; Vannucchi AM; Martinazzo G; Bernabei PA; Ferrini PR Haematologica; 1996; 81(3):201-7. PubMed ID: 8767524 [TBL] [Abstract][Full Text] [Related]
54. Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adults. Barker JN; Davies SM; DeFor TE; Burns LJ; McGlave PB; Miller JS; Weisdorf DJ Br J Haematol; 2002 Jul; 118(1):101-7. PubMed ID: 12100132 [TBL] [Abstract][Full Text] [Related]
55. Bone marrow transplantation for leukaemia in Europe. Gratwohl A; Hermans J; Lyklema A; Zwaan FE Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):353-60. PubMed ID: 2480274 [TBL] [Abstract][Full Text] [Related]
56. Restricted usage of T-cell receptor alpha-chain variable region (TCRAV) and T-cell receptor beta-chain variable region (TCRBV) repertoires after human allogeneic haematopoietic transplantation. Matsutani T; Yoshioka T; Tsuruta Y; Iwagami S; Toyosaki-Maeda T; Horiuchi T; Miura AB; Watanabe A; Takada G; Suzuki R; Hirokawa M Br J Haematol; 2000 Jun; 109(4):759-69. PubMed ID: 10929026 [TBL] [Abstract][Full Text] [Related]
57. Second bone marrow transplantation after leukemia relapse in 11 patients. Wagner JE; Santos GW; Burns WH; Saral R Bone Marrow Transplant; 1989 Jan; 4(1):115-8. PubMed ID: 2647176 [TBL] [Abstract][Full Text] [Related]
58. Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation. Kolb HJ; Bender-Götze C; Holler E; Mittermüller J; Grosse-Wilde H; Wank R; Eckstein R; Scholz S; Haas RJ; Mempel W Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):421-5. PubMed ID: 2480284 [TBL] [Abstract][Full Text] [Related]
59. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. Witherspoon RP; Fisher LD; Schoch G; Martin P; Sullivan KM; Sanders J; Deeg HJ; Doney K; Thomas D; Storb R N Engl J Med; 1989 Sep; 321(12):784-9. PubMed ID: 2671734 [TBL] [Abstract][Full Text] [Related]
60. Allogeneic bone marrow transplantation from HLA-identical siblings following conditioning with busulfan and cyclophosphamide. First results. Wiktor-Jedrzejczak W; Szczylik C; Matej H; Pojda Z; Ratajczak MZ; Myc A; Siekierzyński M; Kansy J; Kłos M; Rybicki Z Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):403-8. PubMed ID: 2480281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]